Award
National Eye Institute 1R01EY038190-01
Elucidating the molecular mechanisms of secondary cone degeneration in models of Retinitis Pigmentosa
Recipient
Massachusetts Eye and Ear Infirmary
Award Amount
$663,406.00
Ceiling
$663,406.00
Awarded
April 02, 2026
Identifier
1R01EY038190-01
This NIH-funded project by Massachusetts Eye and Ear Infirmary aims to elucidate molecular mechanisms of secondary cone degeneration in Retinitis Pigmentosa and develop gene therapy using Retinoic Acid signaling pathway activation.
Description
The project aims to develop a gene therapy approach for Retinitis Pigmentosa using Retinoic Acid signaling pathway activation. The project focuses on molecular mechanisms and therapeutic development for retinal degenerative disease.